• We are a fully integrated vaccine company with two travel vaccines on the market.

  • Dedicated to innovation in vaccine research and development.

  • Valneva’s R&D focuses on vaccines addressing high unmet medical needs.

  • Valneva covers the full value chain from research to market.

Welcome to Valneva
A fully integrated, commercial stage biotech company focused on developing innovative lifesaving vaccines.

2017_full_year_financial_publications.jpg

— March 29, 2018

Valneva to Present on Lyme and Zika at the
18th World Vaccine Congress in Washington, D.C.

Read the press release
 
Download presentations

— Stock information

@valnevase




















-
— March 22, 2018
Valneva Delivers Strong 2017 Financial Results and Advances Key R&D Programs

Read more
— Financial Calendar

May 17, 2018
Q1 2018 Results

See all dates






JAPANESE
ENCEPHALITIS
AND
CHOLERA



learn more
play video Company Video

– Upcoming conferences



Euronext TECH40 Investor Forum
Frankfurt, DE
May 15, 2018 
Please update your browser...